Has BPC-157 been studied in tendon injury?

In rat models. Krivic 2006 examined Achilles detachment and Cerovecki 2010 examined ligament healing, both in the Journal of Orthopaedic Research.

Is there human evidence?

A Phase 2 trial in acute hamstring muscle strain is recruiting, with primary completion due February 2027. No result exists yet.

Do rat tendon results transfer to people?

Not automatically. Scale, loading and healing time course all differ, and a surgical injury differs from a strain sustained in use.

BPC-157 Tendon and Ligament Research

The short answer

Two frequently cited studies in the Journal of Orthopaedic Research examined BPC-157 in musculoskeletal models: Krivic and colleagues on Achilles tendon detachment in 2006, and Cerovecki and colleagues on ligament healing in 2010. Both used rat models.

Key facts

Achilles model: Krivic, J Orthop Res 2006 (PMID 16583442)
Ligament model: Cerovecki, J Orthop Res 2010 (PMID 20225319)
Model organism: Rat
Journal: Journal of Orthopaedic Research
Human equivalent: Phase 2 in hamstring strain, recruiting
Reported result: Improved healing measures in the models

The two studies

Krivic and colleagues examined Achilles tendon detachment in the rat, published in the Journal of Orthopaedic Research in 2006, reporting effects on the tendon-to-bone unit. Cerovecki and colleagues reported that pentadecapeptide BPC 157 improved ligament healing in the rat, in the same journal in 2010. Both appear in a mainstream orthopaedic journal rather than a specialist peptide publication.

Why musculoskeletal models are attractive here

Tendon and ligament heal slowly and poorly, with limited vascular supply, which makes them a demanding test and a clinically meaningful target. They also permit reasonably objective endpoints. Mechanical testing of a healed tendon gives a number rather than an impression.

Research material referenced

BPC-157 5mg, third-party HPLC tested

Buy BPC-157 · £15.99

What a rat tendon model can establish

That a compound alters a healing measure under controlled conditions in that species. Rat tendon healing differs from human in scale, loading and time course, and a surgically created injury differs from a strain sustained in use. These are the standard limitations of animal musculoskeletal models rather than criticisms of these particular studies.

The trial that tests the translation

NCT07437547 is a randomised, double-blind, placebo-controlled Phase 2 trial of BPC 157 in acute hamstring muscle strain. 120 participants, sponsored by Hudson Biotech, started 2 February 2026 with primary completion due 14 February 2027. It is the direct human counterpart to this preclinical thread, which makes the tendon and ligament literature unusually consequential: it is about to be tested.

What is claimed here

Nothing. These are reports of what specific studies measured in rat models, plus a registered trial that has not reported. Material supplied for laboratory research has no relationship to that trial, and no claim is made that BPC-157 heals tendon, ligament or muscle in any person.

Frequently asked questions

Has BPC-157 been studied in tendon injury?: In rat models. Krivic 2006 examined Achilles detachment and Cerovecki 2010 examined ligament healing, both in the Journal of Orthopaedic Research.
Is there human evidence?: A Phase 2 trial in acute hamstring muscle strain is recruiting, with primary completion due February 2027. No result exists yet.
Do rat tendon results transfer to people?: Not automatically. Scale, loading and healing time course all differ, and a surgical injury differs from a strain sustained in use.

Extended research context

The BPC-157 (Pentadecapeptide) deep dive

Deep dive: the pentadecapeptide sequence

BPC-157 is a synthetic pentadecapeptide with the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. It is derived from a fragment identified in human gastric juice by the Zagreb research group (Sikirić and colleagues), whose body of published work spans three decades and covers models ranging from tendon repair to gut integrity. The 'BPC' initials stand for 'body protection compound', the group's original characterisation term.

Two forms: acetate salt vs arginate

BPC-157 is supplied most commonly as an acetate salt; a small subset of suppliers offer the arginate form, which has slightly different solubility and stability properties. For research reproducibility, keep the salt form consistent across a study and confirm which form the CoA specifies (mass ± counterion changes the reading).

Reading a BPC-157 CoA

A trustworthy BPC-157 CoA lists HPLC purity (target ≥98% area), mass-spec confirmation (~1,419 Da for the free peptide), water content (Karl Fischer), acetate content, and residual solvents. Some batches also include endotoxin data. Any missing category is a red flag for a compromised supply chain.

Research applications

▸Cell-culture models of gut epithelial integrity
▸Tendon fibroblast migration and collagen-synthesis assays
▸Angiogenesis models involving VEGF and NO signalling
▸Stability studies comparing acetate vs arginate salt forms
▸Analytical reference for pentadecapeptide HPLC methods

Handling checklist

✓Store lyophilised vial at −20 °C long-term (2–8 °C short-term)
✓Reconstitute with bacteriostatic water; a 5 mg vial dissolves cleanly
✓Aliquot reconstituted solution; keep refrigerated 2–8 °C, use within 28 days
✓Protect from light and repeated warming
✓Verify CoA: HPLC ≥98%, mass ~1,419 Da, salt form declared

Common research-handling mistakes

Learnt from thousands of researcher orders across our UK labs.

✗ Mixing acetate and arginate BPC-157 across a study

Fix: Choose one salt form and stay with it. Different masses and solubility.

✗ Assuming stability at room temperature

Fix: Refrigerate reconstituted solution; discard after 28 days.

✗ Buying without a CoA

Fix: Only source from suppliers that publish batch HPLC + mass-spec data.

Continue researching

Peer-reviewed guides, comparators and matched reference materials.

Primary sources & clinical trials

Peer-reviewed research and registered trials from PubMed, ClinicalTrials.gov, PubChem, FDA and NIH. All links open in a new tab and point to the primary source, so every claim can be verified at origin.

UKP

Written and reviewed by

The UK Peptides Editorial Team · Research library, UK Peptides

The editorial team is responsible for supplier selection, batch release decisions and the content published in this research library. Every article here is sourced to primary literature and every product page to a signed third-party certificate. Corrections are made in place and the review date updated.

How we write and check this content Report a factual error in this article

More BPC-157 (Pentadecapeptide) articles

Popular across the research hub

One flagship guide from every other research category.

← Back to Forum

Tendon and Ligament Models